Atopic dermatitis (AD) is a chronic disease that affects an increasing number of children and adults. The skin is dry and ...

While other triggers are more likely to bring on an atopic dermatitis flare, Megan Rogge, MD, of UT Health in Houston talks about when to consider food allergies and recommend an elimination diet.

A small study recently found that the experimental drug nemolizumab (Mitchga) substantially improved itching in people with atopic dermatitis (AD). These improvements, in turn, were associated with ...

The ADHAND trial has demonstrated that tralokinumab significantly improved skin clarity, itch, and pain in adults with moderate-to-severe hand atopic dermatitis. All primary and secondary ...

Please provide your email address to receive an email when new articles are posted on . Tapinarof cream 1% showed low discontinuation rates. The cream has no restriction of use. Tapinarof patients ...

Managing itch associated with atopic dermatitis is a critical intervention to patient quality of life. Casey Butrus, PharmD: Dr Cameron, what’s the typical onset of action when you’re looking at a ...

Topical ruxolitinib appears to quickly relieve itch in Black patients with atopic dermatitis (AD), an industry-sponsored analysis of pooled data from two studies suggests. "Ruxolitinib cream ...

Among patients with moderate to severe atopic dermatitis, atopic comorbidities did not change the benefits seen with lebrikizumab, according to data published in Annals of Allergy, Asthma & Immunology ...

Rocatinlimab, targeting the OX40 pathway, shows significant efficacy in moderate to severe atopic dermatitis, marking a new therapeutic class in disease management. Long-term melanoma data reveal ...